Respiratory Disease Deaths in Kazakhstan: Rising Trends and Urgent Need for Prevention (2011-2021)

What is it about?

The study analyzed data from the National Statistics Agency of the Republic of Kazakhstan to calculate preventable mortality rates from respiratory diseases between 2011 and 2021. It focused on different age groups, divided into 5-year intervals, and considered gender differences in mortality data. The research found that preventable mortality rates more than doubled by 2021, with a significant increase noted in 2020, reaching 156.19 per 100,000 population. Preventable mortality was consistently higher among men, approximately three or more times than in women. The average annual percentage change in mortality was 7.5% from 2011 to 2021, with a greater increase observed in women than men. The study projects a continued rise in mortality rates by 2026 and emphasizes the need for targeted health strategies to reduce avoidable deaths.

Featured Image

Why is it important?

This study is important as it provides a comprehensive analysis of respiratory disease-related mortality in Kazakhstan over a decade, highlighting the significant rise in preventable deaths. By identifying trends and projecting future mortality rates, the study underscores the urgency for targeted health strategies and policy interventions to mitigate escalating respiratory disease burdens. This research is pivotal for informing health policy, aligning with global health goals, and ensuring effective resource allocation to improve public health outcomes and reduce avoidable deaths in Kazakhstan. Key Takeaways: 1. Rising Mortality Rates: The study reveals that preventable mortality from respiratory diseases in Kazakhstan more than doubled by 2021, with a significant surge during the COVID-19 pandemic, indicating systemic health challenges. 2. Gender Disparities: Findings show that preventable mortality rates are consistently three times higher in men than in women, emphasizing the need for gender-specific health interventions. 3. Projected Increase by 2026: The research projects continued increases in respiratory disease mortality rates by 2026, highlighting the necessity for collaborative efforts between the scientific community and governments to develop effective prevention strategies.